Clinical Trial Update: Short-term Effects of Aromatase Inhibition in Obese Men [Phase 3]

View source ↗

Summary

Phase 3 clinical trial completed evaluating the short-term effects of aromatase inhibition in obese men.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadotropic Hypogonadism
• Obesity

Snippet

Sponsor: Rijnstate Hospital | Conditions: Hypogonadotrophic Hypogonadism, Obesity | Phase 3 | Status: COMPLETED